1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Overview 1.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview 1.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Segment by Type 1.2.1 Surgical Treatment 1.2.2 Minimally Invasive Treatment 1.2.3 Laser Treatment 1.2.4 Other 1.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Type 1.3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Overview by Type (2016-2027) 1.3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Type (2016-2021) 1.4.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Type (2016-2021) 2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Competition by Company 2.1 Global Top Players by Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (2016-2021) 2.2 Global Top Players by Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (2016-2021) 2.3 Global Top Players Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (2016-2021) 2.4 Global Top Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base Distribution, Sales Area, Product Type 2.5 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Competitive Situation and Trends 2.5.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Devices as of 2020) 2.7 Date of Key Manufacturers Enter into Benign Prostatic Hyperplasia (BPH) Treatment Devices Market 2.8 Key Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Status and Outlook by Region 3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Historic Market Size by Region 3.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Volume by Region (2016-2021) 3.2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Value by Region (2016-2021) 3.2.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Forecasted Market Size by Region 3.3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Volume by Region (2022-2027) 3.3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Value by Region (2022-2027) 3.3.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices by Application 4.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Segment by Application 4.1.1 Fertility Clinics 4.1.2 Hospitals 4.1.3 Others 4.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Application 4.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Overview by Application (2016-2027) 4.2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Application (2016-2021) 4.3.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Application (2016-2021) 5 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices by Country 5.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Historic Market Size by Country 5.1.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Volume by Country (2016-2021) 5.1.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Value by Country (2016-2021) 5.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Forecasted Market Size by Country 5.2.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Volume by Country (2022-2027) 5.2.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Value by Country (2022-2027) 6 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices by Country 6.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Historic Market Size by Country 6.1.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Volume by Country (2016-2021) 6.1.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Value by Country (2016-2021) 6.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Forecasted Market Size by Country 6.2.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Volume by Country (2022-2027) 6.2.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Value by Country (2022-2027) 7 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices by Region 7.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Historic Market Size by Region 7.1.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Forecasted Market Size by Region 7.2.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Value by Region (2022-2027) 8 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices by Country 8.1 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Historic Market Size by Country 8.1.1 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Volume by Country (2016-2021) 8.1.2 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Value by Country (2016-2021) 8.2 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Forecasted Market Size by Country 8.2.1 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Volume by Country (2022-2027) 8.2.2 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Value by Country (2022-2027) 9 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices by Country 9.1 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Historic Market Size by Country 9.1.1 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Forecasted Market Size by Country 9.2.1 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Benign Prostatic Hyperplasia (BPH) Treatment Devices Business 10.1 Advin Urology 10.1.1 Advin Urology Corporation Information 10.1.2 Advin Urology Introduction and Business Overview 10.1.3 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 10.1.4 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered 10.1.5 Advin Urology Recent Development 10.2 Biolitec 10.2.1 Biolitec Corporation Information 10.2.2 Biolitec Introduction and Business Overview 10.2.3 Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 10.2.4 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered 10.2.5 Biolitec Recent Development 10.3 Boston Scientific Corporation 10.3.1 Boston Scientific Corporation Corporation Information 10.3.2 Boston Scientific Corporation Introduction and Business Overview 10.3.3 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 10.3.4 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered 10.3.5 Boston Scientific Corporation Recent Development 10.4 CONMED 10.4.1 CONMED Corporation Information 10.4.2 CONMED Introduction and Business Overview 10.4.3 CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 10.4.4 CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered 10.4.5 CONMED Recent Development 10.5 Convergent Laser Technologies 10.5.1 Convergent Laser Technologies Corporation Information 10.5.2 Convergent Laser Technologies Introduction and Business Overview 10.5.3 Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 10.5.4 Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered 10.5.5 Convergent Laser Technologies Recent Development 10.6 CoreTherm Medical, Inc. (ProstaLund) 10.6.1 CoreTherm Medical, Inc. (ProstaLund) Corporation Information 10.6.2 CoreTherm Medical, Inc. (ProstaLund) Introduction and Business Overview 10.6.3 CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 10.6.4 CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered 10.6.5 CoreTherm Medical, Inc. (ProstaLund) Recent Development 10.7 HistoSonics, Inc. 10.7.1 HistoSonics, Inc. Corporation Information 10.7.2 HistoSonics, Inc. Introduction and Business Overview 10.7.3 HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 10.7.4 HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered 10.7.5 HistoSonics, Inc. Recent Development 10.8 JenaSurgical GmbH 10.8.1 JenaSurgical GmbH Corporation Information 10.8.2 JenaSurgical GmbH Introduction and Business Overview 10.8.3 JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 10.8.4 JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered 10.8.5 JenaSurgical GmbH Recent Development 10.9 KARL STORZ 10.9.1 KARL STORZ Corporation Information 10.9.2 KARL STORZ Introduction and Business Overview 10.9.3 KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 10.9.4 KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered 10.9.5 KARL STORZ Recent Development 10.10 LISA Laser Products GmbH 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Category, Application and Specification 10.10.3 LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2016-2021) 10.10.4 Main Business Overview 10.10.5 LISA Laser Products GmbH Recent Development 10.11 Lumenis Ltd. 10.11.1 Lumenis Ltd. Corporation Information 10.11.2 Lumenis Ltd. Introduction and Business Overview 10.11.3 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 10.11.4 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered 10.11.5 Lumenis Ltd. Recent Development 10.12 Medifocus, Inc. 10.12.1 Medifocus, Inc. Corporation Information 10.12.2 Medifocus, Inc. Introduction and Business Overview 10.12.3 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 10.12.4 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered 10.12.5 Medifocus, Inc. Recent Development 10.13 Endo International 10.13.1 Endo International Corporation Information 10.13.2 Endo International Introduction and Business Overview 10.13.3 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 10.13.4 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered 10.13.5 Endo International Recent Development 10.14 Medtronic 10.14.1 Medtronic Corporation Information 10.14.2 Medtronic Introduction and Business Overview 10.14.3 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 10.14.4 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered 10.14.5 Medtronic Recent Development 10.15 Siemens 10.15.1 Siemens Corporation Information 10.15.2 Siemens Introduction and Business Overview 10.15.3 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 10.15.4 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered 10.15.5 Siemens Recent Development 10.16 Olympus 10.16.1 Olympus Corporation Information 10.16.2 Olympus Introduction and Business Overview 10.16.3 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 10.16.4 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered 10.16.5 Olympus Recent Development 10.17 Urologix 10.17.1 Urologix Corporation Information 10.17.2 Urologix Introduction and Business Overview 10.17.3 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 10.17.4 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered 10.17.5 Urologix Recent Development 10.18 NeoTract 10.18.1 NeoTract Corporation Information 10.18.2 NeoTract Introduction and Business Overview 10.18.3 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 10.18.4 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered 10.18.5 NeoTract Recent Development 10.19 Urotech 10.19.1 Urotech Corporation Information 10.19.2 Urotech Introduction and Business Overview 10.19.3 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 10.19.4 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered 10.19.5 Urotech Recent Development 10.20 Baxter International 10.20.1 Baxter International Corporation Information 10.20.2 Baxter International Introduction and Business Overview 10.20.3 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 10.20.4 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered 10.20.5 Baxter International Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Industrial Chain Analysis 11.4 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Distributors 12.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of Surgical Treatment Table 2. Major Company of Minimally Invasive Treatment Table 3. Major Company of Laser Treatment Table 4. Major Company of Other Table 5. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 6. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016-2021) & (K Units) Table 7. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Type (2016-2021) Table 8. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016-2021) & (US& Million) Table 9. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share in Value by Type (2016-2021) Table 10. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Type (2016-2021) & (US$/Unit) Table 11. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2022-2027) & (K Units) Table 12. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Type (2022-2027) Table 13. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2022-2027) & (US$ Million) Table 14. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Type (2022-2027) Table 15. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Type (2022-2027) & (US$/Unit) Table 16. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016-2021) & (K Units) Table 17. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016-2021) & (US$ Million) Table 18. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Type (2016-2021) Table 19. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016-2021) & (US$ Million) Table 20. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Type (2016-2021) Table 21. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016-2021) & (US$ Million) Table 22. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Type (2016-2021) Table 23. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016-2021) & (US$ Million) Table 24. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Type (2016-2021) Table 25. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016-2021) & (US$ Million) Table 26. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Company (2016-2021) & (K Units) Table 27. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Company (2016-2021) Table 28. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Company (2016-2021) & (US$ Million) Table 29. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Company (2016-2021) Table 30. Global Market Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Company (2016-2021) & (US$/Unit) Table 31. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Top Manufacturers Manufacturing Base Distribution and Sales Area Table 32. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Devices as of 2020 Table 34. Date of Key Manufacturers Enter into Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Table 35. Key Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type Table 36. Mergers & Acquisitions, Expansion Plans Table 37. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 38. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2016-2021) & (K Units) Table 39. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Region (2016-2021) Table 40. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2016-2021) & (US$ Million) Table 41. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Region (2016-2021) Table 42. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 43. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2022-2027) & (K Units) Table 44. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Region (2022-2027) Table 45. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2022-2027) & (US$ Million) Table 46. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Region (2022-2027) Table 47. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2022-2027) Table 48. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 49. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2021) & (K Units) Table 50. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Application (2016-2021) Table 51. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2021) & (US$ Million) Table 52. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Application (2016-2021) Table 53. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Application (2016-2021) & (US$/Unit) Table 54. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2022-2027) & (K Units) Table 55. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Application (2022-2027) Table 56. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2022-2027) & (US$ Million) Table 57. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Application (2022-2027) Table 58. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Application (2022-2027) & (US$/Unit) Table 59. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2021) (K Units) Table 60. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2021) & (US$ Million) Table 61. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Application in 2020 Table 62. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2021) (K Units) Table 63. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2021) & (US$ Million) Table 64. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Application in 2020 Table 65. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2021) (K Units) Table 66. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2021) & (US$ Million) Table 67. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Application in 2020 Table 68. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2021) (K Units) Table 69. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2021) & (US$ Million) Table 70. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Application in 2020 Table 71. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2021) (K Units) Table 72. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2021) & (US$ Million) Table 73. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Application in 2020 Table 74. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2016-2021) & (K Units) Table 75. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Country (2016-2021) Table 76. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2016-2021) & (US$ Million) Table 77. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Country (2016-2021) Table 78. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2022-2027) & (K Units) Table 79. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Country (2022-2027) Table 80. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2022-2027) & (US$ Million) Table 81. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Country (2022-2027) Table 82. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2016-2021) & (K Units) Table 83. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Country (2016-2021) Table 84. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2016-2021) & (US$ Million) Table 85. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Country (2016-2021) Table 86. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2022-2027) & (K Units) Table 87. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Country (2022-2027) Table 88. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2022-2027) & (US$ Million) Table 89. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Country (2022-2027) Table 90. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2016-2021) & (K Units) Table 91. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Region (2016-2021) Table 92. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2016-2021) & (US$ Million) Table 93. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Region (2016-2021) Table 94. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2022-2027) & (K Units) Table 95. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Region (2022-2027) Table 96. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2022-2027) & (US$ Million) Table 97. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Region (2022-2027) Table 98. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2016-2021) & (K Units) Table 99. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Country (2016-2021) Table 100. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2016-2021) & (US$ Million) Table 101. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Country (2016-2021) Table 102. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2022-2027) & (K Units) Table 103. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Country (2022-2027) Table 104. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2022-2027) & (US$ Million) Table 105. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Country (2022-2027) Table 106. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2016-2021) & (K Units) Table 107. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Country (2016-2021) Table 108. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2016-2021) & (US$ Million) Table 109. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Country (2016-2021) Table 110. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2022-2027) & (K Units) Table 111. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Country (2022-2027) Table 112. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2022-2027) & (US$ Million) Table 113. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Country (2022-2027) Table 114. Advin Urology Corporation Information Table 115. Advin Urology Introduction and Business Overview Table 116. Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 117. Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Table 118. Advin Urology Recent Development Table 119. Biolitec Corporation Information Table 120. Biolitec Introduction and Business Overview Table 121. Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 122. Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Table 123. Biolitec Recent Development Table 124. Boston Scientific Corporation Corporation Information Table 125. Boston Scientific Corporation Introduction and Business Overview Table 126. Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 127. Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Table 128. Boston Scientific Corporation Recent Development Table 129. CONMED Corporation Information Table 130. CONMED Introduction and Business Overview Table 131. CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 132. CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Table 133. CONMED Recent Development Table 134. Convergent Laser Technologies Corporation Information Table 135. Convergent Laser Technologies Introduction and Business Overview Table 136. Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 137. Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Table 138. Convergent Laser Technologies Recent Development Table 139. CoreTherm Medical, Inc. (ProstaLund) Corporation Information Table 140. CoreTherm Medical, Inc. (ProstaLund) Introduction and Business Overview Table 141. CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 142. CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Table 143. CoreTherm Medical, Inc. (ProstaLund) Recent Development Table 144. HistoSonics, Inc. Corporation Information Table 145. HistoSonics, Inc. Introduction and Business Overview Table 146. HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 147. HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Table 148. HistoSonics, Inc. Recent Development Table 149. JenaSurgical GmbH Corporation Information Table 150. JenaSurgical GmbH Introduction and Business Overview Table 151. JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 152. JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Table 153. JenaSurgical GmbH Recent Development Table 154. KARL STORZ Corporation Information Table 155. KARL STORZ Introduction and Business Overview Table 156. KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 157. KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Table 158. KARL STORZ Recent Development Table 159. LISA Laser Products GmbH Corporation Information Table 160. LISA Laser Products GmbH Introduction and Business Overview Table 161. LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 162. LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Table 163. LISA Laser Products GmbH Recent Development Table 164. Lumenis Ltd. Corporation Information Table 165. Lumenis Ltd. Introduction and Business Overview Table 166. Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 167. Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Table 168. Lumenis Ltd. Recent Development Table 169. Medifocus, Inc. Corporation Information Table 170. Medifocus, Inc. Introduction and Business Overview Table 171. Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 172. Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Table 173. Medifocus, Inc. Recent Development Table 174. Endo International Corporation Information Table 175. Endo International Introduction and Business Overview Table 176. Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 177. Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Table 178. Endo International Recent Development Table 179. Medtronic Corporation Information Table 180. Medtronic Introduction and Business Overview Table 181. Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 182. Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Table 183. Medtronic Recent Development Table 184. Siemens Corporation Information Table 185. Siemens Introduction and Business Overview Table 186. Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 187. Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Table 188. Siemens Recent Development Table 189. Olympus Corporation Information Table 190. Olympus Introduction and Business Overview Table 191. Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 192. Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Table 193. Olympus Recent Development Table 194. Urologix Corporation Information Table 195. Urologix Introduction and Business Overview Table 196. Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 197. Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Table 198. Urologix Recent Development Table 199. NeoTract Corporation Information Table 200. NeoTract Introduction and Business Overview Table 201. NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 202. NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Table 203. NeoTract Recent Development Table 204. Urotech Corporation Information Table 205. Urotech Introduction and Business Overview Table 206. Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 207. Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Table 208. Urotech Recent Development Table 209. Baxter International Corporation Information Table 210. Baxter International Introduction and Business Overview Table 211. Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 212. Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Table 213. Baxter International Recent Development Table 214. Key Raw Materials Lists Table 215. Raw Materials Key Suppliers Lists Table 216. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Trends Table 217. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Drivers Table 218. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Challenges Table 219. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Restraints Table 220. Benign Prostatic Hyperplasia (BPH) Treatment Devices Distributors List Table 221. Benign Prostatic Hyperplasia (BPH) Treatment Devices Downstream Customers Table 222. Research Programs/Design for This Report Table 223. Key Data Information from Secondary Sources Table 224. Key Data Information from Primary Sources List of Figures Figure 1. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Picture Figure 2. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Status and Outlook (2016-2027) & (K Units) Figure 5. Product Picture of Surgical Treatment Figure 6. Global Surgical Treatment Sales YoY Growth (2016-2021) & (K Units) Figure 7. Product Picture of Minimally Invasive Treatment Figure 8. Global Minimally Invasive Treatment Sales YoY Growth (2016-2021) & (K Units) Figure 9. Product Picture of Laser Treatment Figure 10. Global Laser Treatment Sales YoY Growth (2016-2021) & (K Units) Figure 11. Product Picture of Other Figure 12. Global Other Sales YoY Growth (2016-2021) & (K Units) Figure 13. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016-2027) & (US$ Million) Figure 14. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Type (2016-2021) Figure 15. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Type (2016-2021) Figure 16. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Type (2022-2027) Figure 17. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Type (2022-2027) Figure 18. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Type in 2020 Figure 19. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Type in 2020 Figure 20. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Type in 2020 Figure 21. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Type in 2020 Figure 22. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Type in 2020 Figure 23. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Type in 2020 Figure 24. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Type in 2020 Figure 25. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Type in 2020 Figure 26. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Type in 2020 Figure 27. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Type in 2020 Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in 2020 Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue in 2020 Figure 30. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 31. Product Picture of Fertility Clinics Figure 32. Global Fertility Clinics Sales YoY Growth (2016-2027) & (K Units) Figure 33. Product Picture of Hospitals Figure 34. Global Hospitals Sales YoY Growth (2016-2027) & (K Units) Figure 35. Product Picture of Others Figure 36. Global Others Sales YoY Growth (2016-2027) & (K Units) Figure 37. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2027) & (US$ Million) Figure 38. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Application (2016-2021) Figure 39. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Application (2016-2021) Figure 40. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Application (2022-2027) Figure 41. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Volume by Application in 2020 Figure 42. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Application in 2020 Figure 43. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Value by Application in 2020 Figure 44. Key Raw Materials Price Figure 45. Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Cost Structure Figure 46. Benign Prostatic Hyperplasia (BPH) Treatment Devices Industrial Chain Analysis Figure 47. Channels of Distribution Figure 48. Distributors Profiles Figure 49. Bottom-up and Top-down Approaches for This Report Figure 50. Data Triangulation Figure 51. Key Executives Interviewed

Advin Urology Biolitec Boston Scientific Corporation CONMED Convergent Laser Technologies CoreTherm Medical, Inc. (ProstaLund) HistoSonics, Inc. JenaSurgical GmbH KARL STORZ LISA Laser Products GmbH Lumenis Ltd. Medifocus, Inc. Endo International Medtronic Siemens Olympus Urologix NeoTract Urotech Baxter International